Cleveland, Ohio, United States BioMotiv appeared to be the VC, which was created in 2012. The main department of described VC is located in the Cleveland. The company was established in North America in United States.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Aro Biotherapeutics. Among the most popular fund investment industries, there are Biotechnology, Therapeutics.
Considering the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top activity for fund was in 2018.
The standard case for the fund is to invest in rounds with 2-3 partakers. The meaningful sponsors for the fund in investment in the same round are NYU Innovation Venture Fund, Johnson & Johnson Innovation, Innovate Indiana Fund.
Related Funds
| Fund Name | Location |
| 10K Ventures | Berlin, Berlin, Germany |
| Asenza Capital | - |
| Berkeley Angel Network | California, San Francisco, United States |
| CITA Investissement | France, Ile-de-France, Paris |
| Daimler Trucks North America | Oregon, Portland, United States |
| Gocompare.com | Newport, United Kingdom, Wales |
| Hefei Gaoxin Development & Investment Group Company | Anhui, China, Hefei |
| Henry Crown and Company | - |
| HQ Financial Group | Central, Central Region, Singapore |
| Mount Sinai Innovation Partners | - |
| National Capital Consortium for Pediatric Device Innovation | - |
| Olivhan Investments | Dallas, Texas, United States |
| Oval Park Capital | North Carolina, Raleigh, United States |
| Pacific Technology Partners | Seattle, United States, Washington |
| Quality Jobs Fund (QJF) | - |
| RENN Capital | Dallas, Texas, United States |
| Rose Ventures | Madison, United States, Wisconsin |
| SalubrisBio | China, Guangdong, Shenzhen |
| Van Wickle Ventures | Providence, Rhode Island, United States |
| Yael Capital Management Limited | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Amphista Therapeutics | $53M | 17 Mar 2021 | Scotland | ||
Aro Biotherapeutics | $88M | 05 Jan 2021 | Philadelphia, Pennsylvania, United States | ||
| $7M | 07 Apr 2020 | Scotland | |||
Allinaire Therapeutics | $1M | 27 Jan 2017 | Cleveland, Ohio, United States |
– Amphista Therapeutics from Glasgow, Scotland, UK, raised $53m in Series B funding.
– The round was co-led by Forbion and Gilde Healthcare with participation from Novartis Venture Fund, and Eli Lilly and Company, and existing investor BioMotiv and founding investor Advent Life Sciences.
– The new investment will be used to accelerate the company’s pipeline of potent and selective bifunctional molecules, known as ‘Amphistas’ to the clinic and to extend its proprietary TPD platform.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Amphista Therapeutics | $53M | 17 Mar 2021 | Scotland | ||
Aro Biotherapeutics | $88M | 05 Jan 2021 | Philadelphia, Pennsylvania, United States | ||
| $7M | 07 Apr 2020 | Scotland | |||
Allinaire Therapeutics | $1M | 27 Jan 2017 | Cleveland, Ohio, United States |
